Carlyle, Hellman To Take PPD Private For $3.9B
Carlyle and Hellman & Friedman will buy the Wilmington, N.C.-based company for $33.25 per share in cash, representing a per-share premium of 29.6 percent over the target's Sept. 30 closing price, PPD said.
PPD contracts with pharmaceutical, biotechnology, medical device, academic and government clients to perform drug...
Already a subscriber? Click here to login